APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Albumin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Plasma Albumin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchPlasma Albumin Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Albumin Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Plasma Albumin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Albumin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Albumin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Plasma Albumin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Plasma Albumin include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, Shanghai RAAS, Hualan Bio, Shuanglin Bio, Octapharma and LFB Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plasma Albumin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasma Albumin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Albumin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plasma Albumin market size, projected growth trends, production technologies, key applications, and end-use industries.

Plasma Albumin Segment by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Tiantan Bio

Shanghai RAAS

Hualan Bio

Shuanglin Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CBPO

Boya Bio

Biotest

Plasma Albumin Segment by Type

20-25% Concentrations

5% Concentrations

Plasma Albumin Segment by Application

Therapeutics

Excipient

Other

Plasma Albumin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Albumin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plasma Albumin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Plasma Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Plasma Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Plasma Albumin Industry Trends Table 2. Plasma Albumin Industry Drivers Table 3. Plasma Albumin Industry Opportunities and Challenges Table 4. Plasma Albumin Industry Restraints Table 5. Global Plasma Albumin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Plasma Albumin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Plasma Albumin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Plasma Albumin Sales Market Share by Manufacturers Table 9. Global Plasma Albumin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Plasma Albumin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Plasma Albumin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Plasma Albumin Manufacturers, Product Type & Application Table 13. Global Plasma Albumin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Plasma Albumin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 20-25% Concentrations Table 17. Major Manufacturers of 5% Concentrations Table 18. Global Plasma Albumin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Plasma Albumin Sales by Type (2021-2026) & (K Units) Table 20. Global Plasma Albumin Sales by Type (2027-2032) & (K Units) Table 21. Global Plasma Albumin Sales Market Share by Type (2021-2026) Table 22. Global Plasma Albumin Sales Market Share by Type (2027-2032) Table 23. Global Plasma Albumin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Plasma Albumin Revenue by Type (2021-2026) & (K Units) Table 25. Global Plasma Albumin Revenue by Type (2027-2032) & (K Units) Table 26. Global Plasma Albumin Revenue Market Share by Type (2021-2026) Table 27. Global Plasma Albumin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Therapeutics Table 29. Major Manufacturers of Excipient Table 30. Major Manufacturers of Other Table 31. Global Plasma Albumin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Plasma Albumin Sales by Application (2021-2026) & (K Units) Table 33. Global Plasma Albumin Sales by Application (2027-2032) & (K Units) Table 34. Global Plasma Albumin Sales Market Share by Application (2021-2026) Table 35. Global Plasma Albumin Sales Market Share by Application (2027-2032) Table 36. Global Plasma Albumin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Plasma Albumin Revenue by Application (2021-2026) & (K Units) Table 38. Global Plasma Albumin Revenue by Application (2027-2032) & (K Units) Table 39. Global Plasma Albumin Revenue Market Share by Application (2021-2026) Table 40. Global Plasma Albumin Revenue Market Share by Application (2027-2032) Table 41. Global Plasma Albumin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Plasma Albumin Sales by Region (2021-2026) & (K Units) Table 43. Global Plasma Albumin Sales Market Share by Region (2021-2026) Table 44. Global Plasma Albumin Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Plasma Albumin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 48. North America Plasma Albumin Sales by Country (2027-2032) & (K Units) Table 49. Europe Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 51. Europe Plasma Albumin Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Plasma Albumin Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Plasma Albumin Sales by Country (2027-2032) & (K Units) Table 58. Global Plasma Albumin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Plasma Albumin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Plasma Albumin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Plasma Albumin Revenue Market Share by Region (2021-2026) Table 62. Global Plasma Albumin Revenue Market Share by Region (2027-2032) Table 63. Yuanda Shuyang Company Information Table 64. Yuanda Shuyang Business Overview Table 65. Yuanda Shuyang Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yuanda Shuyang Plasma Albumin Product Portfolio Table 67. Yuanda Shuyang Recent Development Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Plasma Albumin Product Portfolio Table 72. Takeda Recent Development Table 73. Weiguang Bio Company Information Table 74. Weiguang Bio Business Overview Table 75. Weiguang Bio Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Weiguang Bio Plasma Albumin Product Portfolio Table 77. Weiguang Bio Recent Development Table 78. Tiantan Bio Company Information Table 79. Tiantan Bio Business Overview Table 80. Tiantan Bio Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tiantan Bio Plasma Albumin Product Portfolio Table 82. Tiantan Bio Recent Development Table 83. Shanghai RAAS Company Information Table 84. Shanghai RAAS Business Overview Table 85. Shanghai RAAS Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shanghai RAAS Plasma Albumin Product Portfolio Table 87. Shanghai RAAS Recent Development Table 88. Hualan Bio Company Information Table 89. Hualan Bio Business Overview Table 90. Hualan Bio Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Hualan Bio Plasma Albumin Product Portfolio Table 92. Hualan Bio Recent Development Table 93. Shuanglin Bio Company Information Table 94. Shuanglin Bio Business Overview Table 95. Shuanglin Bio Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shuanglin Bio Plasma Albumin Product Portfolio Table 97. Shuanglin Bio Recent Development Table 98. Octapharma Company Information Table 99. Octapharma Business Overview Table 100. Octapharma Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Octapharma Plasma Albumin Product Portfolio Table 102. Octapharma Recent Development Table 103. LFB Group Company Information Table 104. LFB Group Business Overview Table 105. LFB Group Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. LFB Group Plasma Albumin Product Portfolio Table 107. LFB Group Recent Development Table 108. Kedrion Company Information Table 109. Kedrion Business Overview Table 110. Kedrion Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Kedrion Plasma Albumin Product Portfolio Table 112. Kedrion Recent Development Table 113. Grifols Company Information Table 114. Grifols Business Overview Table 115. Grifols Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Grifols Plasma Albumin Product Portfolio Table 117. Grifols Recent Development Table 118. CSL Company Information Table 119. CSL Business Overview Table 120. CSL Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. CSL Plasma Albumin Product Portfolio Table 122. CSL Recent Development Table 123. CBPO Company Information Table 124. CBPO Business Overview Table 125. CBPO Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. CBPO Plasma Albumin Product Portfolio Table 127. CBPO Recent Development Table 128. Boya Bio Company Information Table 129. Boya Bio Business Overview Table 130. Boya Bio Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Boya Bio Plasma Albumin Product Portfolio Table 132. Boya Bio Recent Development Table 133. Biotest Company Information Table 134. Biotest Business Overview Table 135. Biotest Plasma Albumin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Biotest Plasma Albumin Product Portfolio Table 137. Biotest Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Plasma Albumin Distributors List Table 141. Plasma Albumin Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Plasma Albumin Product Image Figure 2. Global Plasma Albumin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Albumin Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Albumin Sales (2021-2032) & (K Units) Figure 5. Global Plasma Albumin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Plasma Albumin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 20-25% Concentrations Image Figure 9. 5% Concentrations Image Figure 10. Global Plasma Albumin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Plasma Albumin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Plasma Albumin Sales Market Share by Type (2021-2032) Figure 13. Global Plasma Albumin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Plasma Albumin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Plasma Albumin Revenue Market Share by Type (2021-2032) Figure 16. Therapeutics Image Figure 17. Excipient Image Figure 18. Other Image Figure 19. Global Plasma Albumin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Plasma Albumin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Plasma Albumin Sales Market Share by Application (2021-2032) Figure 22. Global Plasma Albumin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Plasma Albumin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Plasma Albumin Revenue Market Share by Application (2021-2032) Figure 25. North America Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Plasma Albumin Sales Market Share by Country (2021-2032) Figure 27. U.S. Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Plasma Albumin Sales Market Share by Country (2021-2032) Figure 32. Germany Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Plasma Albumin Sales Market Share by Country (2021-2032) Figure 39. China Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Plasma Albumin Sales Market Share by Country (2021-2032) Figure 47. Brazil Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Plasma Albumin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Plasma Albumin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Plasma Albumin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Plasma Albumin Revenue (2021-2032) & (US$ Million) Figure 58. North America Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Plasma Albumin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Plasma Albumin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Plasma Albumin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Plasma Albumin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Plasma Albumin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 20-25% Concentrations
  • 5% Concentrations
Applications
  • Therapeutics
  • Excipient
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • Shanghai RAAS
  • Hualan Bio
  • Shuanglin Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CBPO
  • Boya Bio
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma Albumin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma Albumin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Plasma Albumin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Plasma Albumin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Plasma Albumin Market Dynamics
  1. 2.1 Plasma Albumin Industry Trends
  2. 2.2 Plasma Albumin Industry Drivers
  3. 2.3 Plasma Albumin Industry Opportunities and Challenges
  4. 2.4 Plasma Albumin Industry Restraints
3 Plasma Albumin Market by Manufacturers
  1. 3.1 Global Plasma Albumin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Plasma Albumin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Plasma Albumin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Plasma Albumin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasma Albumin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Plasma Albumin Manufacturers, Product Type & Application
  7. 3.7 Global Plasma Albumin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasma Albumin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasma Albumin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasma Albumin Tier 1, Tier 2, and Tier 3
4 Plasma Albumin Market by Type
  1. 4.1 Plasma Albumin Type Introduction
  2. 4.1.1 20-25% Concentrations
  3. 4.1.2 5% Concentrations
  4. 4.2 Global Plasma Albumin Sales by Type
  5. 4.2.1 Global Plasma Albumin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Plasma Albumin Sales by Type (2021-2032)
  7. 4.2.3 Global Plasma Albumin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Plasma Albumin Revenue by Type
  9. 4.3.1 Global Plasma Albumin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Plasma Albumin Revenue by Type (2021-2032)
  11. 4.3.3 Global Plasma Albumin Revenue Market Share by Type (2021-2032)
5 Plasma Albumin Market by Application
  1. 5.1 Plasma Albumin Application Introduction
  2. 5.1.1 Therapeutics
  3. 5.1.2 Excipient
  4. 5.1.3 Other
  5. 5.2 Global Plasma Albumin Sales by Application
  6. 5.2.1 Global Plasma Albumin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasma Albumin Sales by Application (2021-2032)
  8. 5.2.3 Global Plasma Albumin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Plasma Albumin Revenue by Application
  10. 5.3.1 Global Plasma Albumin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plasma Albumin Revenue by Application (2021-2032)
  12. 5.3.3 Global Plasma Albumin Revenue Market Share by Application (2021-2032)
6 Global Plasma Albumin Sales by Region
  1. 6.1 Global Plasma Albumin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Albumin Sales by Region (2021-2032)
  3. 6.2.1 Global Plasma Albumin Sales by Region (2021-2026)
  4. 6.2.2 Global Plasma Albumin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Plasma Albumin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Plasma Albumin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Plasma Albumin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Plasma Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Plasma Albumin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Plasma Albumin Revenue by Region
  1. 7.1 Global Plasma Albumin Revenue by Region
  2. 7.1.1 Global Plasma Albumin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Plasma Albumin Revenue by Region (2021-2026)
  4. 7.1.3 Global Plasma Albumin Revenue by Region (2027-2032)
  5. 7.1.4 Global Plasma Albumin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Plasma Albumin Revenue (2021-2032)
  8. 7.2.2 North America Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Plasma Albumin Revenue (2021-2032)
  11. 7.3.2 Europe Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Plasma Albumin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Plasma Albumin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Plasma Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuanda Shuyang
  2. 8.1.1 Yuanda Shuyang Company Information
  3. 8.1.2 Yuanda Shuyang Business Overview
  4. 8.1.3 Yuanda Shuyang Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yuanda Shuyang Plasma Albumin Product Portfolio
  6. 8.1.5 Yuanda Shuyang Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Plasma Albumin Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Weiguang Bio
  14. 8.3.1 Weiguang Bio Company Information
  15. 8.3.2 Weiguang Bio Business Overview
  16. 8.3.3 Weiguang Bio Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Weiguang Bio Plasma Albumin Product Portfolio
  18. 8.3.5 Weiguang Bio Recent Developments
  19. 8.4 Tiantan Bio
  20. 8.4.1 Tiantan Bio Company Information
  21. 8.4.2 Tiantan Bio Business Overview
  22. 8.4.3 Tiantan Bio Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tiantan Bio Plasma Albumin Product Portfolio
  24. 8.4.5 Tiantan Bio Recent Developments
  25. 8.5 Shanghai RAAS
  26. 8.5.1 Shanghai RAAS Company Information
  27. 8.5.2 Shanghai RAAS Business Overview
  28. 8.5.3 Shanghai RAAS Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai RAAS Plasma Albumin Product Portfolio
  30. 8.5.5 Shanghai RAAS Recent Developments
  31. 8.6 Hualan Bio
  32. 8.6.1 Hualan Bio Company Information
  33. 8.6.2 Hualan Bio Business Overview
  34. 8.6.3 Hualan Bio Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Bio Plasma Albumin Product Portfolio
  36. 8.6.5 Hualan Bio Recent Developments
  37. 8.7 Shuanglin Bio
  38. 8.7.1 Shuanglin Bio Company Information
  39. 8.7.2 Shuanglin Bio Business Overview
  40. 8.7.3 Shuanglin Bio Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shuanglin Bio Plasma Albumin Product Portfolio
  42. 8.7.5 Shuanglin Bio Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Plasma Albumin Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 LFB Group
  50. 8.9.1 LFB Group Company Information
  51. 8.9.2 LFB Group Business Overview
  52. 8.9.3 LFB Group Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LFB Group Plasma Albumin Product Portfolio
  54. 8.9.5 LFB Group Recent Developments
  55. 8.10 Kedrion
  56. 8.10.1 Kedrion Company Information
  57. 8.10.2 Kedrion Business Overview
  58. 8.10.3 Kedrion Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kedrion Plasma Albumin Product Portfolio
  60. 8.10.5 Kedrion Recent Developments
  61. 8.11 Grifols
  62. 8.11.1 Grifols Company Information
  63. 8.11.2 Grifols Business Overview
  64. 8.11.3 Grifols Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Grifols Plasma Albumin Product Portfolio
  66. 8.11.5 Grifols Recent Developments
  67. 8.12 CSL
  68. 8.12.1 CSL Company Information
  69. 8.12.2 CSL Business Overview
  70. 8.12.3 CSL Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CSL Plasma Albumin Product Portfolio
  72. 8.12.5 CSL Recent Developments
  73. 8.13 CBPO
  74. 8.13.1 CBPO Company Information
  75. 8.13.2 CBPO Business Overview
  76. 8.13.3 CBPO Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CBPO Plasma Albumin Product Portfolio
  78. 8.13.5 CBPO Recent Developments
  79. 8.14 Boya Bio
  80. 8.14.1 Boya Bio Company Information
  81. 8.14.2 Boya Bio Business Overview
  82. 8.14.3 Boya Bio Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boya Bio Plasma Albumin Product Portfolio
  84. 8.14.5 Boya Bio Recent Developments
  85. 8.15 Biotest
  86. 8.15.1 Biotest Company Information
  87. 8.15.2 Biotest Business Overview
  88. 8.15.3 Biotest Plasma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biotest Plasma Albumin Product Portfolio
  90. 8.15.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plasma Albumin Value Chain Analysis
  2. 9.1.1 Plasma Albumin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plasma Albumin Production Mode & Process
  6. 9.2 Plasma Albumin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plasma Albumin Distributors
  9. 9.2.3 Plasma Albumin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst